scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S11906-006-0088-6 |
P698 | PubMed publication ID | 16965729 |
P2093 | author name string | Paul Light | |
P2860 | cites work | Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients | Q74592658 |
Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients | Q74631556 | ||
Central pulse pressure and mortality in end-stage renal disease | Q77773119 | ||
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis | Q77814884 | ||
Clinical and biochemical correlates of starting "daily" hemodialysis | Q77829508 | ||
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study | Q78351858 | ||
ACE inhibitors and survival of hemodialysis patients | Q78450239 | ||
Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients | Q81371337 | ||
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 | ||
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration | Q34482868 | ||
Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. | Q35145471 | ||
Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities | Q35989502 | ||
The natural history of myocardial disease in dialysis patients | Q37105885 | ||
A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients | Q40678986 | ||
Long-term evolution of cardiomyopathy in dialysis patients | Q40832956 | ||
Patients surviving 10 years of hemodialysis | Q41444843 | ||
Control of blood pressure in long slow hemodialysis | Q43490098 | ||
Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease | Q43556781 | ||
Importance of blood pressure control in hemodialysis patient survival | Q44056994 | ||
Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study | Q44269772 | ||
Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients | Q44474451 | ||
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial | Q46522431 | ||
Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients | Q47246878 | ||
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States | Q47633391 | ||
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis | Q50144395 | ||
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. | Q50614527 | ||
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. | Q50872408 | ||
Predictors of stroke in patients receiving chronic hemodialysis. | Q50993173 | ||
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. | Q51560834 | ||
Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. | Q52310447 | ||
Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients. | Q54160724 | ||
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin | Q57914022 | ||
Long‐term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end‐stage renal failure patients | Q62131717 | ||
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study | Q64111823 | ||
Role of arterial hypertension in left ventricle hypertrophy in hemodialysis patients: an echocardiographic study | Q67546947 | ||
Survival as an index of adequacy of dialysis | Q68174197 | ||
The clinical course of left ventricular hypertrophy in dialysis patients | Q68421125 | ||
Hypertension in dialysis patients: a cross-sectional analysis | Q71296097 | ||
The role of hypertension in hemodialysis-associated atherosclerosis | Q72129068 | ||
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy | Q72192935 | ||
Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy | Q72651976 | ||
Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients | Q73183003 | ||
Hypertension in the hemodialysis population: any relation to one-year survival? | Q73353454 | ||
Calcium channel blocker use and mortality among patients with end-stage renal disease | Q74168778 | ||
Hypertension in the haemodialysis population: any relationship to 2-years survival? | Q74532313 | ||
P433 | issue | 5 | |
P921 | main subject | renal dialysis | Q202301 |
P304 | page(s) | 413-419 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | Current Hypertension Reports | Q15746362 |
P1476 | title | Current understanding of optimal blood pressure goals in dialysis patients | |
P478 | volume | 8 |
Q37058718 | Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients | cites work | P2860 |
Search more.